Clinical Trials
9 trialsNCT07556276 2026-04-29
Study of CMTS1215 Injection in Patients With Solid Tumors
The Second Hospital of Nanjing Medical University
Phase 1/2 Recruiting
NCT07245901 2025-11-24
Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1/2 Not yet recruiting
NCT02992210 2025-09-08
Study on GD2 Positive Solid Tumors by 4SCAR-GD2
Shenzhen Geno-Immune Medical Institute
Phase 1/2 Recruiting
NCT03707808 2025-01-20
myDAvIpNi
Universitair Ziekenhuis Brussel
Phase 1/2 Recruiting
NCT05576961 2024-01-23
Safety and Efficacy of RX-af01 Combined With PD-1 Antibody
Sun Yat-sen University
Phase 1/2 Unknown
NCT05833984 2023-04-27
Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1/2 Unknown
NCT05748938 2023-03-01
A Study of RD14-01 in Patients With Advanced Solid Tumors
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Phase 1/2 Unknown
NCT05437315 2022-06-29
GD2/PSMA Bi-specific CAR-T Cell Therapy
Shenzhen Geno-Immune Medical Institute
Phase 1/2 Recruiting
NCT04432649 2020-06-16
Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276
Shenzhen Geno-Immune Medical Institute
Phase 1/2 Unknown